JNC 7 血壓分期. 血壓分期 JNC 7 ： 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003.

Slides:

Advertisements

Similar presentations

1 ENVOLVING THE FUTURE OF SINGLE PILL COMBINATION IN ANTIHYPERTENSIVE THERAPHY Djanggan Sargowo Shangri-La, Surabaya - Sabtu, 23 Juni 2012.

Advertisements

1 Antihypertensive Medication Use and the Risk of Cardiovascular Malformations Alissa R. Caton, Ph.D. NYS Department of Health MCH Epidemiology Conference.

Hypertension arterielle Cours de DCEM Rabih R. Azar, MD, MSc, FACC Division of Cardiology Hotel-Dieu de France Hospital.

The Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Internal Medicine/Pediatrics.

JNC 8 Guidelines….

The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure

Hypertension – Summary

BLOOD PRESSURE Systolic Diastolic.

Hypertension Diagnosis and Treatment  Based on JNC 7 – published in 2003  Goal: BP

Management of Hypertension according to JNC 7 BY SANDAR KYI, MD.

Hypertension: JNC 7 Guidelines Steven W Harris MHS PA-C.

WHEN SHOULD ONE INITIATE SUCCESSIVE ANTIHYPERTENSIVE DRUGS? Henry R. Black M.D. RUSH University Medical Center Chicago, IL June 15, 2005.

Drugs for Hypertension

1 The JNC 7 recommendations for initial or combination drug therapy are based on sound scientific evidence.

Hypertension Jared Helms D.O. OGME-2 22 August 2007.

Improving the Care of the Hypertensive Patient: US Perspective William Cushman, MD Professor, Preventive Medicine and Medicine University of Tennessee.

1 1 Individualized Therapy forHypertension Introduction to Primary Care: a course of the Center of Post Graduate Studies in FM PO Box – Riyadh

Selection of Antihypertensive Drug. BP ClassificationSystolic BP, mm Hg Diastolic BP, mm Hg Normal

Daily Dilemmas in Hypertension Management. Objectives Review the impact of hypertension on society Review the impact of hypertension on society Review.

Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal

Report from the panel members appointed to the Eighth Joint National Committee (JNC 8) 2014 evidence-based guidelines for the management of high blood.

DION GALLANT, MD PRIMARY CARE SERVICE LINE MEDICAL DIRECTOR PRESBYTERIAN MEDICAL GROUP JNC 8.

1 Antihypertensive Trial Outcome Differences: Diuretic vs. Calcium Channel Blocker Compared to participants assigned to the diuretic, those assigned to.

10 Points to Remember on An Effective Approach to High Blood Pressure ControlAn Effective Approach to High Blood Pressure Control Summary Prepared by Debabrata.

1 Current & New treatment strategies to address CV Risk.

UPDATE ON MANAGEMENT OF HYPERTENSION. Classification of BLOOD PRESSURE for adults 18 yrs. Or older BP ClassificationSystolic BP, mm of hgDiastolic BP,

吴永健中国医学科学院北京协和医学院心血管病研究所阜外心血管医院

Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.

New Guidelines for Myocardial Ischemia Management.

Objective: To asses the efficacy of hydrochlorothiazide on 24-h blood pressure (BP) control.Methods: Review of all the randomized trials that assessed.

Pre-ALLHAT Drug Use IMS Health NDTI, Year % of Treated Patients on Medication CCBs Beta Blockers Diuretics ACE Inhibitors.

JNC 7 blood pressure classification in adults aged ≥18 years BP Classification SBP (mm HG) DBP (mm HG) Normal

Relationship of background ACEI dose to benefits of candesartan in the CHARM-Added trial.

1 ALLHAT Antihypertensive Trial Results by Baseline Diabetic Status January 28, 2004.

HYPERTENTION AND CKD YASER EL HENDY MD.

Therapeutics Conference. Fluid Resuscitation Early correction of fluid deficit is essential in hypovolemic shock to prevent decline in tissue perfusion.

Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Renoprotective Effect of Renin-Angiotensin-Aldosterone.

April 22, 2016 Connie Tien Daniel Kim Jeffrey Hughes Michelle Di Fiore

Management of Hypertension according to JNC 7

David Antecol, M.D., FACC, FASH, FRCP(C) Specialist in Clinical Hypertension (American Society of Hypertension) Disclosures: None.

JNC VIII Hypertension.

Aaron P Kithcart Giuseppe Curigliano Joshua A. Beckman Cardio-Oncology

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

Drugs for Hypertension

Why wasn’t a beta-blocker tested as first-line therapy?

Achieving the Clinical Potential of RAAS Blockade

Current and future paradigm for prognostication and testing of therapeutics in patients with heart failure using machine learning. Current and future paradigm.

Hypertension: A Risk Factor For Stroke

UNIT 2: ANTIHYPERTENSIVE DRUGS

WHI Observational Study: Cardiovascular death in women with hypertension but no history of CVD on monotherapy CVD death Diuretic, HR (95% CI) ACE inhibitor,

Mean BP from initial visit to four years

Drug Rate ratio 95% CI Thiazide diuretics 1.0 Reference ACE inhibitors

UNIT 2: ANTIHYPERTENSIVE DRUGS

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or ARB is suggested to treat hypertension.

Essential Hypertension

Table of Contents Why Do We Treat Hypertension? Recommendation 5

The Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) Study was a double-blind, randomized, placebo-controlled study.

Beth Wallace, BSN, RN-BC, FNP-S Fairfield University Summer 2010

Primary Hypertension Max C. Reif, M.D.

Volume 72, Issue 12, Pages (December 2007)

Managing Blood Pressure

JNC Evidence-Based Guideline for the Management of

Volume 73, Issue 5, Pages (March 2008)

JNC Evidence-Based Guideline for the Management of

Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)

Expected value of perfect implementation: population net health benefit and maximum justifiable investment if all patients who were eligible received beta.

(A) Distribution of CsA nephrotoxicity lesions according to antihypertensive treatment and CsA C2 levels. (A) Distribution of CsA nephrotoxicity lesions.

Unadjusted odds ratio of death at 6 mo for medications (β blockers [BBL], angiotensin-converting enzyme inhibitors [ACEI]/angiotensin receptor blockers.

Recommendations for the treatment of confirmed hypertension in people with diabetes. *An ACE inhibitor (ACEi) or angiotensin receptor blocker (ARB) is.

An updated general approach for achieving BP goals in people with diabetes. An updated general approach for achieving BP goals in people with diabetes.

Presentation transcript:

JNC 7 血壓分期

血壓分期 JNC 7 ： 1. 增加高血壓前期 2.Stages 2 及 3 高血壓被合併 JNC 7, 2003

JNC VII ACE-I = angiotensin-converting enzyme inhibitor; ARB = angiotensin-receptor blocker; BB = beta blocker; CCB = calcium channel blocker. Chobanian AV et al. JAMA. 2003;289: Drug(s) for the compelling indications; other antihypertensive drugs (diuretics, ACE-I, ARB, BB, CCB) as needed BP Classification Lifestyle Modification Initial Drug Therapy Without Compelling Indication With Compelling Indication Normal <120/80 mm Hg Prehypertension /80-89 mm Hg Stage 1 hypertension /90-99 mm Hg Stage 2 hypertension ≥ 160/100 mm Hg Encourage Yes No drug indicated Drug(s) for the compelling indications Thiazide-type diuretics for most; may consider ACE-I, ARB, BB, CCB, or combination 2-drug combination for most (usually thiazide-type diuretic and ACE-I, ARB, BB, or CCB)